Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
STOK

Updated 10/6/2026, 12:12 PM ET.

STOK

Stoke Therapeutics, Inc.

Sale$16,509

Allan Jonathan

GENERAL COUNSEL & CORP SEC

627 shat $26.33Filed Oct 2, 5:37 PM ET
Filing
STOK

Stoke Therapeutics, Inc.

Sale$27,494

Ticho Barry

CHIEF MEDICAL OFFICER

1,051 shat $26.16Filed Oct 2, 5:35 PM ET
Filing
STOK

Stoke Therapeutics, Inc.

Sale$170,061

Ticho Barry

CHIEF MEDICAL OFFICER

5,545 shat $30.67Filed Sep 3, 4:17 PM ET
Filing
STOK

Stoke Therapeutics, Inc.

Sale$152,690

Ticho Barry

CHIEF MEDICAL OFFICER

4,767 shat $32.03Filed Aug 18, 8:29 PM ETFiling
STOK

Stoke Therapeutics, Inc.

Sale$402,528

Kaye Edward M. MD

Director

12,567 shat $32.03Filed Aug 18, 8:28 PM ETFiling
STOK

Stoke Therapeutics, Inc.

Sale$91,639

Allan Jonathan

GENERAL COUNSEL & CORP SEC

2,861 shat $32.03Filed Aug 18, 8:27 PM ETFiling
STOK

Stoke Therapeutics, Inc.

Sale$208,385

Ticho Barry

CHIEF MEDICAL OFFICER

7,176 shat $29.04Filed Aug 5, 4:17 PM ET
Filing

Read from public SEC filings. Not financial advice.